Introduction to the Seranostics Business

We would like to introduce a project aimed at the integration of imaging diagnosis and treatment using radiopharmaceuticals!

Theranostics, which closely links treatment and diagnosis, is expected to contribute to personalized medicine and the effective use of healthcare costs. By developing therapeutic agents using radioisotopes (RI: radioactive isotopes) that emit alpha particles, a type of radiation, along with companion diagnostic agents, we aim to realize theranostics. We have completed the CRADLE building and established the "Theranostics Production Technology Center." By placing a dedicated department, we will achieve the early supply of alpha-emitting radionuclides from the CRADLE building, while further strengthening collaboration between the drug discovery laboratory located within the same facility and the Chiba factory, thereby accelerating the development of theranostics drug discovery. 【Functions of the facility】 ■ Production of 225Ac and PET radionuclides ■ Handling of 177Lu and 211At, among others ■ Production of investigational drugs ■ Production of research-use RIs *For more details, please refer to the PDF document or feel free to contact us.

Other contract manufacturingOther contract servicesPharmaceutical intermediate manufacturing services